Form D · Other
Grazer Labs, Inc.
New York, NY · CIK 0001671408
Offering snapshot reported Apr 8, 2016 · SEC filing
- Reported sold
- $2.15M Indefinite offering
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 24, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2016 | Initial | $2,149,215 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-260935
Source: Form D, filed Apr 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Dee | Director, Executive |
| Nicholas Devane | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
219 Bowery #2
New York, NY, 10002
New York, NY, 10002